World

Top 946 largest Companies in the Biotechnology industry in the World by Market Cap

This is the list of the largest public listed companies in the Biotechnology industry in the world by market capitalization with links to their reference stock.

World Biotechnology Industry Analysis
World Top Companies World Companies Analysis

Top Biotechnology Companies in the World as of Jan. 01, 2026

Rank Company Market Cap (USD) Country Sector Industry
331 Zota Health Care Ltd $520.4 M India Indian Healthcare Indian Biotechnology
332 Design Therapeutics, Inc. $518.4 M United States US Healthcare US Biotechnology
333 Qingdao Vland Biotech, Inc. $517.2 M China Chinese Healthcare Chinese Biotechnology
334 Sosei Group Corp $512.2 M Japan Japanese Healthcare Japanese Biotechnology
335 Autolus Therapeutics plc $497.7 M United Kingdom UK Healthcare UK Biotechnology
336 Cellectis SA $496.6 M France French Healthcare French Biotechnology
337 Prothena Corporation plc $495.2 M Ireland Irish Healthcare Irish Biotechnology
338 Akouos, Inc. $491.0 M

(Nov. 1, 2022)

 United States US Healthcare US Biotechnology
339 Vanda Pharmaceuticals Inc. $487.5 M United States US Healthcare US Biotechnology
340 ChromaDex Corporation $483.3 M United States US Healthcare US Biotechnology
341 VectivBio Holding AG $474.9 M

(Jan. 1, 2023)

 Switzerland Swiss Healthcare Swiss Biotechnology
342 Ever Supreme Bio Technology Co. Ltd $469.8 M Taiwan Taiwanese Healthcare Taiwanese Biotechnology
343 Guangdong VTR Bio-Tech Co. Ltd $469.7 M China Chinese Healthcare Chinese Biotechnology
344 Tanvex BioPharma, Inc. $467.5 M Cayman Islands Cayman Islands Healthcare Cayman Islands Biotechnology
345 Sinovac Biotech Ltd. $464.9 M China Chinese Healthcare Chinese Biotechnology
346 Bicycle Therapeutics plc $463.4 M United Kingdom UK Healthcare UK Biotechnology
347 NervGen Pharma Corp $458.3 M Canada Canadian Healthcare Canadian Biotechnology
348 SIGA Technologies, Inc. $449.0 M United States US Healthcare US Biotechnology
349 PYC Therapeutics Limited $437.6 M

(July 1, 2024)

 Australia Australian Healthcare Australian Biotechnology
350 Eton Pharmaceuticals, Inc. $436.1 M United States US Healthcare US Biotechnology
351 ADC Therapeutics SA $436.0 M Switzerland Swiss Healthcare Swiss Biotechnology
352 Hainan Huluwa Pharmaceutical Group Co. Ltd $434.6 M China Chinese Healthcare Chinese Biotechnology
353 Ocugen, Inc. $431.0 M United States US Healthcare US Biotechnology
354 Cybin, Inc. $421.6 M Canada Canadian Healthcare Canadian Biotechnology
355 4D Molecular Therapeutics, Inc. $418.2 M United States US Healthcare US Biotechnology
356 Enanta Pharmaceuticals, Inc. $416.2 M United States US Healthcare US Biotechnology
357 Lexicon Pharmaceuticals, Inc. $414.3 M United States US Healthcare US Biotechnology
358 IMARA Inc. $413.7 M United States US Healthcare US Biotechnology
359 DiaMedica Therapeutics Inc. $413.0 M United States US Healthcare US Biotechnology
360 Akebia Therapeutics, Inc. $411.3 M United States US Healthcare US Biotechnology

Top Biotechnology Companies in the World as of Jan. 01, 2026

331. Zota Health Care Ltd

Company Profile: Zota Health Care Ltd
Market Cap (USD): $520.4 M
Country: India
Sector: Indian Healthcare
Industry: Indian Biotechnology

332. Design Therapeutics, Inc.

Company Profile: Design Therapeutics, Inc.
Market Cap (USD): $518.4 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

333. Qingdao Vland Biotech, Inc.

Company Profile: Qingdao Vland Biotech, Inc.
Market Cap (USD): $517.2 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

334. Sosei Group Corp

Company Profile: Sosei Group Corp
Market Cap (USD): $512.2 M
Country: Japan
Sector: Japanese Healthcare
Industry: Japanese Biotechnology

335. Autolus Therapeutics plc

Company Profile: Autolus Therapeutics plc
Market Cap (USD): $497.7 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

336. Cellectis SA

Company Profile: Cellectis SA
Market Cap (USD): $496.6 M
Country: France
Sector: French Healthcare
Industry: French Biotechnology

337. Prothena Corporation plc

Company Profile: Prothena Corporation plc
Market Cap (USD): $495.2 M
Country: Ireland
Sector: Irish Healthcare
Industry: Irish Biotechnology

338. Akouos, Inc.

Company Profile: Akouos, Inc.
Market Cap (USD): $491.0 M (Nov. 1, 2022)
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

339. Vanda Pharmaceuticals Inc.

Company Profile: Vanda Pharmaceuticals Inc.
Market Cap (USD): $487.5 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

340. ChromaDex Corporation

Company Profile: ChromaDex Corporation
Market Cap (USD): $483.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

341. VectivBio Holding AG

Company Profile: VectivBio Holding AG
Market Cap (USD): $474.9 M (Jan. 1, 2023)
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

342. Ever Supreme Bio Technology Co. Ltd

Company Profile: Ever Supreme Bio Technology Co. Ltd
Market Cap (USD): $469.8 M
Country: Taiwan
Sector: Taiwanese Healthcare
Industry: Taiwanese Biotechnology

343. Guangdong VTR Bio-Tech Co. Ltd

Company Profile: Guangdong VTR Bio-Tech Co. Ltd
Market Cap (USD): $469.7 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

344. Tanvex BioPharma, Inc.

Company Profile: Tanvex BioPharma, Inc.
Market Cap (USD): $467.5 M
Country: Cayman Islands
Sector: Cayman Islands Healthcare
Industry: Cayman Islands Biotechnology

345. Sinovac Biotech Ltd.

Company Profile: Sinovac Biotech Ltd.
Market Cap (USD): $464.9 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

346. Bicycle Therapeutics plc

Company Profile: Bicycle Therapeutics plc
Market Cap (USD): $463.4 M
Country: United Kingdom
Sector: UK Healthcare
Industry: UK Biotechnology

347. NervGen Pharma Corp

Company Profile: NervGen Pharma Corp
Market Cap (USD): $458.3 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

348. SIGA Technologies, Inc.

Company Profile: SIGA Technologies, Inc.
Market Cap (USD): $449.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

349. PYC Therapeutics Limited

Company Profile: PYC Therapeutics Limited
Market Cap (USD): $437.6 M (July 1, 2024)
Country: Australia
Sector: Australian Healthcare
Industry: Australian Biotechnology

350. Eton Pharmaceuticals, Inc.

Company Profile: Eton Pharmaceuticals, Inc.
Market Cap (USD): $436.1 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

351. ADC Therapeutics SA

Company Profile: ADC Therapeutics SA
Market Cap (USD): $436.0 M
Country: Switzerland
Sector: Swiss Healthcare
Industry: Swiss Biotechnology

352. Hainan Huluwa Pharmaceutical Group Co. Ltd

Company Profile: Hainan Huluwa Pharmaceutical Group Co. Ltd
Market Cap (USD): $434.6 M
Country: China
Sector: Chinese Healthcare
Industry: Chinese Biotechnology

353. Ocugen, Inc.

Company Profile: Ocugen, Inc.
Market Cap (USD): $431.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

354. Cybin, Inc.

Company Profile: Cybin, Inc.
Market Cap (USD): $421.6 M
Country: Canada
Sector: Canadian Healthcare
Industry: Canadian Biotechnology

355. 4D Molecular Therapeutics, Inc.

Company Profile: 4D Molecular Therapeutics, Inc.
Market Cap (USD): $418.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

356. Enanta Pharmaceuticals, Inc.

Company Profile: Enanta Pharmaceuticals, Inc.
Market Cap (USD): $416.2 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

357. Lexicon Pharmaceuticals, Inc.

Company Profile: Lexicon Pharmaceuticals, Inc.
Market Cap (USD): $414.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

358. IMARA Inc.

Company Profile: IMARA Inc.
Market Cap (USD): $413.7 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

359. DiaMedica Therapeutics Inc.

Company Profile: DiaMedica Therapeutics Inc.
Market Cap (USD): $413.0 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

360. Akebia Therapeutics, Inc.

Company Profile: Akebia Therapeutics, Inc.
Market Cap (USD): $411.3 M
Country: United States
Sector: US Healthcare
Industry: US Biotechnology

Stay in touch